Search

Your search keyword '"Castaman G"' showing total 579 results

Search Constraints

Start Over You searched for: Author "Castaman G" Remove constraint Author: "Castaman G" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
579 results on '"Castaman G"'

Search Results

1. Obstacles to Early Diagnosis and Treatment of Inherited von Willebrand Disease: Current Perspectives

2. Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence

3. Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A

4. Determinants of bleeding before and during immune tolerance in 222 boys with severe hemophilia A and inhibitors >5 BU

5. The value‐based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia

7. PCR191 Assessing Quality of Care in Haemophilia Using a Value-Based Healthcare Approach

15. PB0642 Determinants of the Bleeding Phenotype in Persons with Non-Severe Hemophilia

16. Phase 1, single‐dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia

18. Translational readthrough at F8 nonsense variants in factor VIII B domain contributes to residual expression and lowers inhibitor association

19. Determinants of bleeding before and during immune tolerance in 222 boys with severe hemophilia A and inhibitors >5 BU

20. Inhibitor development and mortality in non‐severe hemophilia A

24. LARGE DELETIONS IN THE F8 GENE PREDICT IMMUNE TOLERANCE INDUCTION FAILURE IN PEOPLE WITH SEVERE HEMOPHILIA A

26. Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors

28. The bleeding phenotype in people with nonsevere hemophilia

30. The factor VIII treatment history of non-severe hemophilia A

31. The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology

34. Real-world clinical and psychosocial outcomes among people with mild or moderate haemophilia A treated on-demand in the Italian CHESS II cohort: a real-world data analysis

38. Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

41. Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study

48. Variability of treatment modalities and intensity in patients with severe haemophilia A on prophylaxis: results from the Italian national registry

49. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD)

50. Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project

Catalog

Books, media, physical & digital resources